Elevated expression of interleukin‐9 mRNA in the bronchial mucosa of atopic asthmatics and allergen‐induced cutaneous late‐phase reaction: relationships to eosinophils, mast cells and T lymphocytes

Clinical and Experimental Allergy - Tập 32 Số 6 - Trang 866-871 - 2002
Ying Sun1, Q. Meng1, A.B. Kay1, Douglas S. Robinson1
1Department of Allergy and Clinical Immunology, National Heart and Lung Institute, Faculty of Medicine, Imperial College, London, UK

Tóm tắt

Summary

Background Interleukin‐9 is a T cell‐derived Th2‐type cytokine that has been linked to airway hyper‐responsiveness, mucus hypersecretion and mast cell infiltration in animal models. We recently demonstrated the potential for IL‐9 to act in human eosinophil development and survival.

Objectives The aims of this study were: (i) to compare IL‐9 mRNA expression in bronchial biopsies between atopic asthmatics and normal controls, (ii) to investigate kinetic expression of IL‐9 mRNA in skin biopsies after allergen challenge; and (iii) to relate IL‐9 expression to infiltration of eosinophils, mast cell and T lymphocytes in local tissue.

Methods Bronchial biopsies were obtained from atopic asthmatics (n = 12) and normal non‐asthmatics (n = 12) at baseline. Skin biopsies were obtained from atopic subjects (n = 11) at 1, 3, 6, 24, 48 and 72 h after allergen challenge. Diluent challenge sites at 24 h were used as controls. IL‐9 mRNA was identified using the technique of in situ hybridization. The numbers of eosinophils, mast cells and T cells were evaluated by immunohistochemistry.

Results The numbers of IL‐9 mRNA+ cells present in the bronchial mucosa were significantly greater in atopic asthmatics than those in normal controls (P = 0.003). The numbers of eosinophils, but not mast cells, were also significantly higher in asthmatics (P < 0.005). The numbers of IL‐9 mRNA+ cells present in the airway of asthmatics significantly correlated with the numbers of eosinophils (r = 0.623, P = 0.03), but not mast cells or T cells. Compared with diluent challenge, the numbers of IL‐9 mRNA+ cells were significantly elevated at all allergen‐challenged sites in the skin, with maximal signals at 48 h (P < 0.005). At 72 h, the numbers of IL‐9 mRNA+ cells significantly correlated with the numbers of eosinophils (r = 0.707, P = 0.015).

Conclusion Elevated expression of IL‐9 in allergic inflammation may contribute to local eosinophil infiltration and survival in asthma and other allergic atopic diseases.

Từ khóa


Tài liệu tham khảo

10.1136/thx.24.2.176

10.1136/thx.8.3.207

10.1136/jcp.13.1.27

10.1164/ajrccm/139.1.242

10.1016/S0163-7258(00)00091-7

Sanderson CJ, 1992, Interleukin 5, eosinophils and disease, Blood, 79, 3101, 10.1182/blood.V79.12.3101.bloodjournal79123101

Kelleher K, 1991, Human interleukin‐9: genomic sequence, chromosomal location, and sequences essential for its expression in human T‐cell leukemia virus (HTLV)‐1‐transformed human T cells, Blood, 77, 1436, 10.1182/blood.V77.7.1436.1436

10.1164/ajrccm.153.4.8616554

10.3109/08830189809043001

Van Snick J, 1989, Cloning and characterization of a CDNA for a new mouse T cell growth factor (P40), J Exp Med, 169, 363, 10.1084/jem.169.1.363

10.1002/eji.1830191130

Hultner L, 1990, Mast cell growth‐enhancing activity (MEA) is structurally related and fuctionally identical to the novel mouse T cell growth factor P40/TCGF III (interleukin 9), Eur J Immunol, 20, 1413, 10.1002/eji.1830200632

Godfraind C, 1998, Intraepithelial infiltration by mast cells with both connective tissue‐type and mucosal‐type characteristics in gut, trachea, and kidneys of IL‐9 transgenic mice, J Immunol, 160, 3989, 10.4049/jimmunol.160.8.3989

10.1084/jem.188.7.1307

10.1165/ajrcmb.19.5.3457

10.1182/blood.V96.6.2163.h8002163_2163_2171

Shimbara A, 1999, IL‐9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma, J Allergy Clin Immnol, 104, 108

Ying S, 1999, Eosinophil chemokitactic chemokines (eotaxin, eotaxin‐2, RANTES, MCP‐3, and MCP‐4) and CCR3 expression in bronchial biopsies from atopic and non‐atopic (intrinsic) asthma, J Immunol, 163, 6321, 10.4049/jimmunol.163.11.6321

10.1165/ajrcmb.16.1.8998072

Ying S, 1999, C‐C chemokines in allergen‐induced late‐phase cutaneous responses in atopic subjects: association of eotaxin with early 6‐hour eosinophils, and eotaxin‐2 and MCP‐4 with the later 24‐hour tissue eosinophilia, and relationship to basophils and other C‐C chemokines (MCP‐3 and RANTES), J Immunol, 163, 3976, 10.4049/jimmunol.163.7.3976

10.1016/1043-4666(90)90037-T

10.4049/jimmunol.164.11.5549

10.1073/pnas.97.2.767

10.1002/(SICI)1521-4141(199907)29:07<2130::AID-IMMU2130>3.0.CO;2-S

10.1165/ajrcmb.25.3.4349

10.1182/blood.V97.4.1035

10.1165/ajrcmb.12.5.7742012

10.1016/S1074-7613(00)00056-X

10.1172/JCI6097

10.1165/ajrcmb.22.6.3927

10.1016/S0140-6736(00)03496-6

Thông tin
Thông tin xuất bản

Clinical and Experimental Allergy

Tập 32 Số 6

866-871

Thông tin tác giả